TrialNeurobiology of aging2006

Alpha-1-antichymotrypsin (ACT or SERPINA3) polymorphism may affect age-at-onset and disease duration of Alzheimer's disease.

M Ilyas Kamboh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.